Dr. Jin Lee, MD

Dr. Lee practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Lee's NPI, 1639349111, was assigned on March 11, 2008. Dr. Lee graduated from Tufts University School Of Medicine in 2002. Dr. Lee holds California license A109932.

Dr. Lee's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Lee's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Lee to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices. Vendor and product names are available with a free account.

Dermatology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lee is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lee's licenses on file in 4 states: California, Colorado, Massachusetts and New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, scalp rash and skin cyst among the conditions Dr. Lee treats.

CMS data shows 778 Medicare services from Dr. Lee across 9 procedure codes in 2024, for 137 Medicare patients. Medicare paid $34,916 for them. Every service was in an office.

CMS counts 137 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 81 patients. 58% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 60, with 60% women.

In 2024, Dr. Lee wrote 395 Medicare Part D claims for 116 patients. 91% of them were for generic drugs. CMS names the drug for 284 of them, across 15 drugs with 11 or more claims each, at $21,856 in total drug cost. In 2023, CMS named 339 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 265 procedures of removal of skin lesions by Dr. Lee, more than 81% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Lee, published from 2015 to 2017. 2017 was the busiest year, with 2. The most frequent topics are Dental Implants, Dental Implantation, Endosseous and Dental Prosthesis Retention. Dr. Lee has published most often in Arch Dermatol.

CMS Open Payments shows 65 general payments to Dr. Lee from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Pfizer Inc. paid the most, $1,409.

Dmand AI lists 2 awards for Dr. Lee, most recently San Diego Top Docs in 2020.

Dr. Lee graduated from Tufts University School Of Medicine in 2002.

Dr. Lee is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.